Rituximab Therapy for Adult Refractory Systemic Lupus Erythematosus with Neurological and/or Psychiatric Presentations: A PRISMACompliant Meta-Analysis
Mehran Asad AyoubiMaryam MoghaddassiMehdi AlooshPublished in: Current rheumatology reviews (2024)
RTX therapy had good effectiveness. The pooled evidence for safety outcomes was
limited and of low certainty.
Keyphrases
- systematic review
- systemic lupus erythematosus
- meta analyses
- disease activity
- randomized controlled trial
- mental health
- hodgkin lymphoma
- case control
- chronic lymphocytic leukemia
- rheumatoid arthritis
- type diabetes
- stem cells
- childhood cancer
- insulin resistance
- brain injury
- blood brain barrier
- bone marrow
- weight loss
- mesenchymal stem cells
- replacement therapy